One‐year intranasal application of growth hormone releasing peptide‐2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient

Background In Japan, growth hormone releasing peptide‐2 (GHRP‐2) is clinically used as a diagnostic agent for growth hormone secretion deficiency, but the therapeutic application of GHRP‐2 has not been studied in anorexia nervosa. GHRP‐2 reportedly exhibits agonistic action for ghrelin receptor and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cachexia, sarcopenia and muscle sarcopenia and muscle, 2015-09, Vol.6 (3), p.237-241
Hauptverfasser:	Haruta, Izumi, Fuku, Yuki, Kinoshita, Kazuhisa, Yoneda, Koichi, Morinaga, Akinori, Amitani, Marie, Amitani, Haruka, Asakawa, Akihiro, Sugawara, Hideki, Takeda, Yasuo, Bowers, Cyril Y., Inui, Akio
Format:	Artikel
Sprache:	eng
Schlagworte:	Anorexia Anorexia nervosa Appetite Body weight Fatigue Food Ghrelin GHRP‐2 Growth factors Growth hormones Hypoglycemia IGF‐1 Insulin Original Peptides Proteins Sleep
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!